Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Else Nutrition Holdings ( (TSE:BABY) ) has shared an update.
Else Nutrition reported that 2025 was a transformative year marked by funding constraints, inventory shortages, and a strategic overhaul of its operations in Canada and the U.S. The company shifted to a direct retail model in Canada, changed logistics providers in the U.S., reduced headcount, and cut total operating expenses by 51%, helping it return to a positive gross profit of $320,000 and target a 30% gross margin in 2026.
Despite more than 60% cuts to sales and marketing and an 18.5% decline in U.S. revenue driven by out-of-stock periods, underlying demand remained strong, particularly online, and margins improved as cost of goods sold fell sharply. Management expects profitability within 12 months and sees major long-term upside from its plant-based infant formula program as recent U.S. regulatory moves, including new FDA guidance on protein efficiency testing, signal growing support for novel, non-dairy, non-soy infant nutrition solutions.
The most recent analyst rating on (TSE:BABY) stock is a Hold with a C$0.09 price target. To see the full list of analyst forecasts on Else Nutrition Holdings stock, see the TSE:BABY Stock Forecast page.
Spark’s Take on BABY Stock
According to Spark, TipRanks’ AI Analyst, BABY is a Neutral.
The score is weighed down primarily by weak financial performance (revenue contraction, negative gross profit, continued losses, negative equity, and ongoing cash burn). Technical indicators are only modestly supportive (some short-term improvement but a weaker longer-term trend), while valuation is not compelling given the negative P/E and no dividend yield.
To see Spark’s full report on BABY stock, click here.
More about Else Nutrition Holdings
Else Nutrition Holdings is a plant-based nutrition company focused on developing dairy- and soy-free products for infants, toddlers, and children. Its portfolio includes cereals, ready-to-drink kids’ beverages, and a flagship plant-based infant formula under development, with a primary market focus on North America through both retail and online channels.
Average Trading Volume: 106,189
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$2.06M
Learn more about BABY stock on TipRanks’ Stock Analysis page.